SPARC and urothelial carcinoma: In hepatocellular carcinoma, miR-29a-3p suppressed cell growth by inhibition of Secreted protein acidic and rich in cysteine (SPARC) [25] while SPARC-deficient mice were shown to develop urothelial carcinoma much earlier than mice expressing SPARC [26].